HK2 Cancer Research Results

HK2, Hexokinase 2: Click to Expand ⟱
Source:
Type: enzyme
HK2 (Hexokinase 2) is an enzyme that plays a crucial role in glycolysis, the process by which cells convert glucose into energy. HK2 is a key regulatory enzyme in the glycolytic pathway, and it is primarily expressed in various tissues, including muscle, brain, and cancer cells.
HK2 has been shown to be overexpressed in many types of tumors, including breast, lung, and colon cancer. This overexpression may contribute to the development and progression of cancer by promoting glycolysis and energy production in cancer cells.
HK2 is a key regulatory enzyme in the glycolytic pathway.
HK2 plays a role in the regulation of glucose metabolism in diabetes.
HK2 is involved in the regulation of cell proliferation, apoptosis, and autophagy.

HK2 Inhibitors:
-2DG
-Curcumin
-Resveratrol
-EGCG
-Berberine
-Methyl Jasmonate (MJ)
-Honokiol


Scientific Papers found: Click to Expand⟱
1143- CHr,    Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2
- in-vitro, HCC, HepG2 - in-vivo, NA, NA - in-vitro, HCC, HepG3 - in-vitro, HCC, HUH7
HK2↓, GlucoseCon↓, lactateProd↓, Glycolysis↓, Apoptosis↑,
6161- Cin,    Cinnamon bark extract suppresses metastatic dissemination of cancer cells through inhibition of glycolytic metabolism
- in-vivo, BC, MDA-MB-231
TumMeta↓, HK2↓, TumCI↓, TumCMig↓, Glycolysis↓, G6PD↓,
1274- Cin,    Cinnamon bark extract suppresses metastatic dissemination of cancer cells through inhibition of glycolytic metabolism
- vitro+vivo, BC, MDA-MB-231
TumCI↓, G6PD↓, HK2↓, Glycolysis↓, TumMeta↓,
1593- Citrate,    Citrate Induces Apoptotic Cell Death: A Promising Way to Treat Gastric Carcinoma?
- in-vitro, GC, BGC-823 - in-vitro, GC, SGC-7901
PFK↓, Glycolysis↓, tumCV↓, cl‑Casp3↑, cl‑PARP↑, Apoptosis↑, ATP↓, ChemoSen↑, Mcl-1↓, glucoNG↑, FBPase↑, OXPHOS↓, TCA↓, β-oxidation↓, HK2↓, PDH↓, ROS↑,
1585- Citrate,    Sodium citrate targeting Ca2+/CAMKK2 pathway exhibits anti-tumor activity through inducing apoptosis and ferroptosis in ovarian cancer
- in-vitro, Ovarian, SKOV3 - in-vitro, Ovarian, A2780S - in-vitro, Nor, HEK293
Apoptosis↑, Ferroptosis↑, Ca+2↓, CaMKII ↓, Akt↓, mTOR↓, Hif1a↓, ROS↑, ChemoSen↑, Casp3↑, Casp9↑, BAX↑, Bcl-2↓, Cyt‑c↑, GlucoseCon↓, lactateProd↓, Pyruv↓, GLUT1↓, HK2↓, PFKP↓, Glycolysis↓, Hif1a↓, p‑Akt↓, p‑mTOR↓, Iron↑, lipid-P↑, MDA↑, ROS↑, H2O2↑, mtDam↑, GSH↓, GPx↓, GPx4↓, NADPH/NADP+↓, eff↓, FTH1↓, LC3‑Ⅱ/LC3‑Ⅰ↑, NCOA4↑, eff↓, TumCG↓,
1576- Citrate,    Targeting citrate as a novel therapeutic strategy in cancer treatment
- Review, Var, NA
TCA↓, T-Cell↝, Glycolysis↓, PKM2↓, PFK2?, SDH↓, PDH↓, β-oxidation↓, CPT1A↓, FASN↑, Casp3↑, Casp2↑, Casp8↑, Casp9↑, cl‑PARP↑, Hif1a↓, GLUT1↓, angioG↓, Ca+2↓, ROS↓, eff↓, Dose↓, Synergy↑, Mcl-1↓, HK2↓, IGF-1R↓, PTEN↑, citrate↓, Dose∅, ChemoSen↑, eff↑, eff↑, Synergy↑,
990- CUR,    Curcumin inhibits aerobic glycolysis and induces mitochondrial-mediated apoptosis through hexokinase II in human colorectal cancer cells in vitro
- in-vitro, CRC, HCT116 - in-vitro, CRC, HT-29
HK2↓, Glycolysis↓, Apoptosis↑,
6223- CUR,    Curcumin Rewires the Tumor Metabolic Landscape: Mechanisms and Clinical Prospects
- Review, Var, NA
Ferroptosis↑, GutMicro↑, Akt↓, mTOR↓, NF-kB↓, Wnt↓, β-catenin/ZEB1↓, STAT3↓, TumCP↓, TumCI↓, TumMeta↓, AMPK↑, P53↑, NRF2↑, TumCCA↑, Apoptosis↑, Casp↑, GPx4↓, DNMTs↓, HDAC↓, VEGF↓, Imm↑, NK cell↑, Warburg↓, Hif1a↓, HK2↓, PKM2↓, LDHA↓, GLUT1↓, MCT1↓, AMPK↑, FASN↓, SCD1↓, GLS↓, Apoptosis↑, ETC↓, MMP↓, ROS↑, lipid-P↑, ChemoSen↑, PDK1 / PDPK1↓, Beclin-1/ATG6↓, ATP↓, Glycolysis↓, GlucoseCon↓, lactateProd↑, MMPs↓, GSH↓, G6PD↓, OXPHOS↓, SREBP2↓, COX2/PTGS2↓, AP-1↓, NADH↓, NRF2↑, HO-1↑, Iron↑, MDA↑, *ROS↓, *Inflam↓,
2308- CUR,    Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells
- in-vitro, Liver, HepG2
GlucoseCon↓, lactateProd↓, ECAR↓, NO↓, ROS↑, HK2↓, PFK1↓, GAPDH↓, PKM2↓, LDHA↓, FASN↓, GLUT1↓, MCT1↓, MCT4↓, HCAR1↓, SDH↑, ChemoSen↑, ROS↑, BioAv↑, P53↑, NF-kB↓, pH↑,
6677- Deg,    Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis
- in-vitro, NSCLC, NA
Glycolysis↓, TumCG↓, Akt↓, Apoptosis↑, TumCP↓, HK2↓, PI3K↓, cMyc↓,
6691- DFC,    Diclofenac impairs the proliferation and glucose metabolism of triple-negative breast cancer cells by targeting the c-Myc pathway
- in-vitro, Melanoma, NA - in-vitro, BC, MDA-MB-231 - in-vitro, BC, HCC1937 - in-vitro, BC, MCF7
Glycolysis↓, Apoptosis↑, cMyc↓, GLUT1↓, TumCP↓, HK2↓, TumCP↓,
1861- dietFMD,  Chemo,    Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models
- in-vitro, Colon, CT26 - in-vivo, NA, NA
selectivity↑, ChemoSen↑, BG↓, AminoA↓, Warburg↓, OCR↑, ATP↓, ROS↑, Apoptosis↑, GlucoseCon↓, PI3K↓, PTEN↑, GLUT1↓, GLUT2↓, HK2↓, PFK1↓, PKA↓, ATP:AMP↓, Glycolysis↓, lactateProd↓,
2272- dietMet,    Methionine restriction - Association with redox homeostasis and implications on aging and diseases
- Review, Nor, NA
*OS↑, *mt-ROS↓, *H2S↑, *FGF21↑, *cognitive↑, *GutMicro↑, *IGF-1↓, *mTOR↓, *GSH↑, *SOD↑, *MDA↓, *NRF2↑, *HO-1↑, *NQO1↑, *GLUT4↑, *Glycolysis↑, *HK2↑, *PFK↑, *PKM2↑, *GlucoseCon↑, *ATF4↑, *PPARα↑, GSH↓, GSTs↑, ROS↑, *neuroP↑,
2309- EGCG,  Chemo,    Targeting Glycolysis with Epigallocatechin-3-Gallate Enhances the Efficacy of Chemotherapeutics in Pancreatic Cancer Cells and Xenografts
- in-vitro, PC, MIA PaCa-2 - in-vitro, Nor, HPNE - in-vitro, PC, PANC1 - in-vivo, NA, NA
TumCG↓, eff↑, ROS↑, ECAR↓, ChemoSen↑, selectivity↑, Glycolysis↓, PFK↓, PKA↓, HK2∅, LDHA∅, PFKP↓, PKM2↓, H2O2↑, TumW↓,
2993- EGCG,    Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells
- in-vitro, Pca, LNCaP
TumCG↓, PSA↓, HK2↓, AR↓, Sp1/3/4↓,
2458- EGCG,  QC,    Identification of plant-based hexokinase 2 inhibitors: combined molecular docking and dynamics simulation studies
- Analysis, Nor, NA
HK2↓,
2459- EGCG,    Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2‑mediated glycolysis
- in-vitro, Tong, Tca8113 - in-vitro, Tong, TSCCa
EGFR↓, Akt↓, ERK↓, HK2↓, GlucoseCon↓, lactateProd↓, Glycolysis↓,
2460- EGCG,  Taur,    Anti-fibrosis activity of combination therapy with epigallocatechin gallate, taurine and genistein by regulating glycolysis, gluconeogenesis, and ribosomal and lysosomal signaling pathways in HSC-T6 cells
- in-vitro, Nor, HSC-T6
HK2↓,
649- EGCG,  CUR,  PI,    Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets
- Review, Var, NA
*BioEnh↑, EGFR↓, HER2/EBBR2↓, IGF-1↓, MAPK↓, ERK↓, RAS↓, Raf↓, NF-kB↓, p‑pRB↓, TumCCA↑, Glycolysis↓, Warburg↓, HK2↓, Pyruv↓,
681- EGCG,    Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models
- vitro+vivo, BC, NA
Casp3↑, Casp8↑, Casp9↑, TumAuto↑, Beclin-1/ATG6↝, ATG5↝, GlucoseCon↓, lactateProd↓, ATP↝, HK2↓, LDHA↓, Hif1a↓, GLUT1↓, TumVol↓, VEGF↓,
6823- EMD,    Role of emodin to prevent gastrointestinal cancers: recent trends and future prospective
- Review, Var, NA
AntiCan↑, *antiOx↑, *chemoP↑, *Inflam↓, TumCP↓, TumMeta↓, TumCCA↑, MAPK↑, BAX↑, Casp↑, ROS↑, *BioAv↓, other↝, TumCI↓, EMT↓, TumCG↑, Apoptosis↑, TumCP↑, MMP2↓, Casp3↑, ChemoSen↑, PI3K↓, Akt↓, Cyt‑c↑, cl‑PARP↑, MMP↓, Warburg↓, HK2↓, PKM2↓, LDHA↓, mtDam↑, Apoptosis↑, N-cadherin↓, Vim↓, E-cadherin↑, eff↑, eff↑, eff↑, toxicity↝, toxicity↑,
2422- EMD,    Anti-Cancer Effects of Emodin on HepG2 Cells as Revealed by 1H NMR Based Metabolic Profiling
- in-vitro, HCC, HepG2
HK2↓, PKM2↓, LDHA↓, Glycolysis↓, TumCCA↑, ROS↓, glut↓, Hif1a↓,
6862- FBZ,    Research: The Urgent Need for Clinical Studies to Evaluate the Anti-Tumor Efficacy of Fenbendazole
- Review, Var, NA
mitA↑, Apoptosis↑, GLUT4↓, HK2↓, Warburg↓, TumCCA↑, P53↑, Casp↑, TumCP↓, ROS↑, Ferroptosis↑, TumVol↓, Dose↝, BioAv↓, RadioS↝, ChemoSen↑,
6853- FBZ,    Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways
- vitro+vivo, Lung, A549 - in-vitro, Lung, H460
TumCD↑, P53↑, GlucoseCon↓, GLUT4↓, HK2↓, TumCG↓, P-gp/ABCB1∅, TumCCA↑, CycB/CCNB1↓, eff↑, selectivity↑, MMP↓, lactateProd↓, Synergy↑, Dose↝, TumCG↓,
6857- FBZ,    Fenbendazole induces pyroptosis in breast cancer cells through HK2/caspase-3/GSDME signaling pathway
- vitro+vivo, BC, NA
tumCV↓, Pyro↑, cl‑Casp3↑, GSDME↑, IL1β↑, Glycolysis↓, HK2↓, TumVol↓, TumW↓, toxicity↓,
2313- Flav,    Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism
- Review, Var, NA
Warburg↓, antiOx↑, angioG↓, Glycolysis↓, PKM2↓, PKM2:PKM1↓, β-catenin/ZEB1↓, cMyc↓, HK2↓, Akt↓, mTOR↓, GLUT1↓, Hif1a↓,
7286- GGB,    Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer
- in-vitro, Lung, A549 - in-vitro, Lung, PC9
Hif1a↓, Glycolysis↓, OXPHOS↑, ROS↑, Apoptosis↑, toxicity↓, PDKs↓, HK2↓, LDHA↓, PFKFB2↓, PKM2↓, Synergy↑,
2438- Gra,    Emerging therapeutic potential of graviola and its constituents in cancers
- Review, Var, NA
Hif1a↓, GLUT1↓, GLUT4↓, HK2↓, LDHA↓, MUC4↓, TumCCA↑, MMP↓, NF-kB↓, ROS↓, Bax:Bcl2↑, ER(estro)↓, cycD1/CCND1↓, chemoPv↑, hepatoP↑,
845- Gra,    A Review on Annona muricata and Its Anticancer Activity
- Review, Var, NA
GlucoseCon↓, ATP↓, HIF-1↓, GLUT1↓, GLUT4↓, HK2↓, LDHA↓, ERK↓, Akt↓, Apoptosis↑, NF-kB↓, ROS↑, Bax:Bcl2↑, MMP↓, Casp3↑, Casp9↑, p‑JNK↓,
836- Gra,    Graviola: A Novel Promising Natural-Derived Drug That Inhibits Tumorigenicity and Metastasis of Pancreatic Cancer Cells In Vitro and In Vivo Through Altering Cell Metabolism
- vitro+vivo, PC, NA
Hif1a↓, NF-kB↓, GLUT1↓, GLUT4↓, HK2↓, LDHA↓, TumCCA↑, TumMeta↓, GlucoseCon↓, ATP↓, necrosis↑, Casp∅, p‑FAK↓, MMP9↓, MUC4↓,
1232- Gra,    Graviola: A Systematic Review on Its Anticancer Properties
- Review, Var, NA
EGFR↓, cycD1/CCND1↓, Bcl-2↓, TumCCA↑, Apoptosis↑, ROS↑, MMP↓, BAX↑, Cyt‑c↑, Hif1a↓, NF-kB↓, GLUT1↓, GLUT4↓, HK2↓, LDHA↓, ATP↓,
2512- H2,    Hydrogen Attenuates Allergic Inflammation by Reversing Energy Metabolic Pathway Switch
- in-vivo, Asthma, NA
*selectivity↑, *lactateProd↓, *ATP↑, *HK2↓, *PFK↓, *Hif1a↓, *PGC-1α↑, *Glycolysis↓, *OXPHOS↑, *Dose↝, *antiAll↑,
960- HNK,    Honokiol Inhibits HIF-1α-Mediated Glycolysis to Halt Breast Cancer Growth
- vitro+vivo, BC, MCF7 - vitro+vivo, BC, MDA-MB-231
OCR↑, ECAR↓, GlucoseCon↓, lactateProd↓, ATP↓, Glycolysis↓, Hif1a↓, GLUT1↓, HK2↓, PDK1 / PDPK1↓, Apoptosis↑, LDHA↓,
9244- ISO, IH,    Isorhamnetin inhibits bladder cancer progression by mediating glycolysis through targeting the SRC/PI3K/Akt axis
- in-vitro, Bladder, 5637
TumCP↓, TumCMig↓, TumCI↓, TumCA↓, Glycolysis↓, TumCCA↑, Apoptosis↑, p‑Src↓, PI3K↓, Akt↓, mTOR↓, HK2↓, GLUT1↓, PFKFB3↓, ECAR↓, OCR↓, GlucoseCon↓, lactateProd↓,
9177- ITCs,  SFN,    Dietary Isothiocyanates: Novel Insights into the Potential for Cancer Prevention and Therapy
- Review, Var, NA
CSCs↓, GutMicro↑, Bacteria↓, TumCCA↑, Apoptosis↑, TumAuto↑, angioG↓, TumCI↓, TumMeta↓, NRF2↑, Glycolysis↓, Wnt↓, β-catenin/ZEB1↓, HH↓, NOTCH↓, NK cell↑, EMT↓, angioG↓, BioAv↓, BioAv↑, AntiBio↑, Bacteria↓, HK2↓, PDH↓, OXPHOS↓, AKT1↓, ACC1↓, FASN↓, ACC-α↓, ACLY↓, SREBP1/SREBF1↓, OCT4↓, Nanog↓, YAP/TEAD↓, miR-21↓, miR-29b↓, ALDH1A1↓, miR-140↑, CD44↓, BMI1↓, miR-200c↑, TumCG↓, TumCI↓, TumCMig↓, E-cadherin↑, N-cadherin↓, Vim↓, α-SMA↓, Slug↓, Snail↓, Twist↓, DNAdam⇅, BioAv↓, ChemoSen↑,
1070- IVM,    Ivermectin accelerates autophagic death of glioma cells by inhibiting glycolysis through blocking GLUT4 mediated JAK/STAT signaling pathway activation
- vitro+vivo, GBM, NA
TumCG↓, LC3II↑, p62↓, ATP↓, Pyruv↓, GlucoseCon↑, HK2↓, PFK1↓, GLUT4↓, Glycolysis↓, JAK2↓, p‑STAT3↓, p‑STAT5↓,
8089- KAE,    Kaempferol impairs aerobic glycolysis against melanoma metastasis via inhibiting the mitochondrial binding of HK2 and VDAC1
- in-vitro, Melanoma, A375 - in-vitro, Melanoma, B16-F10
TumCMig↓, TumCI↓, TumMeta↓, ECAR↓, GlucoseCon↓, ATP↓, Pyruv↓, lactateProd↓, HK2↓, VDAC1↓, Akt↓, GSK‐3β↝, Glycolysis↓,
8101- KAE,    Kaempferol inhibits cell proliferation and glycolysis in esophagus squamous cell carcinoma via targeting EGFR signaling pathway
- vitro+vivo, ESCC, KYSE150 - vitro+vivo, ESCC, Eca109
TumCCA↑, TumCP↓, Glycolysis↓, HK2↓, GlucoseCon↓, lactateProd↓, EGFR↓, TumCG↓, P21↑, Dose↝, Ki-67↓,
8147- Lae,    Mechanisms underlying the therapeutic effects of Amygdalin in treating Cervical Cancer based on multi-omics analysis
- in-vitro, Cerv, Ca9-22 - in-vitro, Cerv, HeLa
TumCP↓, Apoptosis↑, TumCCA↑, HK2↓, CAIX/CA9↓,
2351- lamb,    Anti-Warburg effect via generation of ROS and inhibition of PKM2/β-catenin mediates apoptosis of lambertianic acid in prostate cancer cells
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3
proCasp3↓, proPARP↓, LDHA↓, Glycolysis↓, HK2↓, PKM2↓, lactateProd↓, p‑STAT3↓, cycD1/CCND1↓, cMyc↓, β-catenin/ZEB1↓, p‑GSK‐3β↓, ROS↑, eff↓, Warburg↓,
8237- LCA,    Role of Licochalcone A in Potential Pharmacological Therapy: A Review
- Review, Var, NA
*other↝, *Inflam↓, *Bacteria↓, *antiOx↑, *AntiP↑, *neuroP↑, *glucose↝, *lipid-P↓, PKCδ↓, P70S6K↓, Akt↓, ER Stress↑, Apoptosis↑, Ca+2↑, PI3K↓, mTOR↓, Casp3↑, Bcl-2↓, Cyt‑c↑, BAX↑, cl‑PARP↑, cycD1/CCND1↑, ROS↑, CHOP/DDIT3↑, ERK↑, p38↑, JNK↓, IAP1↓, XIAP↓, survivin↓, cFLIP↓, RIP1↓, EGFR↓, MET↓, HER2/EBBR2↓, p‑4E-BP1↓, PERK↑, eIF2α↑, PD-L1↓, HK2↓, Glycolysis↓, Sp1/3/4↓, FasL↑, MMP↓, ATP↓, TumAuto↑, WEE1↑, P21↑, CDK1↓, TumCCA↑, TumCMig↓, TumCI↓, ABCG2↓, HSP90↓, T-Cell↑, CD4+↑, CD25+↑, FOXP3↑, Imm↝, *Inflam↓, *NF-kB↓, *NRF2↑, *AntiArt↑, *antiAll↑, *MUC5AC↓, *E-sel↓, *CCL11↓,
8235- LCA,    Anticancer effects of licochalcones: A review of the mechanisms
- Review, Var, NA
mt-Apoptosis↑, TumAuto↑, TumCMig↓, LC3‑Ⅱ/LC3‑Ⅰ↑, ATG5↑, ATG7↑, p62↑, CHOP/DDIT3↑, ER Stress↑, UPR↑, ATG3↑, Beclin-1/ATG6↑, ATG16L1↑, PERK↑, ATF4↑, ATP↓, Hif1a↓, GLUT1↓, PDK1 / PDPK1↓, Bcl-xL↓, Bcl-2↓, BAD↑, BAX↑, Casp3↑, survivin↓, EGFR↓, ERK↓, Akt↓, mtDam↑, MMP↓, Cyt‑c↑, Casp↑, MDM2↓, CycB/CCNB1↓, CDC2↓, CDC25↓, TumCCA↑, TumCP↓, Wnt↓, β-catenin/ZEB1↓, Sp1/3/4↓, MMP-10↓, MMP3↓, TumCI↓, Imm↑, PD-L1↓, ROS↑, 4E-BP1↓, eIF2α↓, PI3K↓, mTOR↓, p‑cMET↑, Ca+2↑, RUBCN↓, ATG13↑, TSC1↑, TSC2↑, PRAS40↑, PP2A↑, ULK1/ATG1↑, THEM4/CTMP↑, DR5↑, Fas↑, TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, PKCδ↓, P70S6K↓, VEGF↓, angioG↓, HK2↓, Glycolysis↓, TrxR1↓, APAF1↑, cl‑PARP↑, Bax:Bcl2↑, ABCG2↓, BioEnh↑,
8281- LE,    A Licorice Roots Extract Induces Apoptosis and Cell Cycle Arrest and Improves Metabolism via Regulating MiRNAs in Liver Cancer Cells
- in-vitro, Liver, NA
Apoptosis↑, TumCCA↑, Let-7↑, miR-34b-5p↑, miR-122-5p↑, miR-126↑, miR-195↑, miR-199↑, miR-206↑, miR-326-5p↑, Hif1a↓, PI3K↓, cMyc↓, AMPK↑, P53↑, Glycolysis↓, HK2↓, LDHA↓, PKM2↓, PPP↓, G6PD↓, GlutaM↓, GLS↓, miR-21↑, miR-221↑, miR-222↑,
2453- LE,    The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors
- Review, Var, NA
HK2↓, PI3K↓, Akt↓, TumCP↓, Glycolysis↓,
2929- LT,    Loss of BRCA1 in the cells of origin of ovarian cancer induces glycolysis: A window of opportunity for ovarian cancer chemoprevention
- in-vitro, Ovarian, NA
HK2↓, Myc↓, Glycolysis↓,
8513- MAG,    Magnolia extract is effective for the chemoprevention of oral cancer through its ability to inhibit mitochondrial respiration at complex I
- vitro+vivo, Oral, SCC4 - in-vitro, Tong, SCC9 - in-vitro, SCC, CAL27
TumCG↓, TumMeta↓, *toxicity↓, Ingr?, chemoPv↑, compI↓, mitResp↓, ETC↓, AMPK↑, STAT3↓, ox-PrxI↑, Dose↝, Ki-67↓, STAT3↓, P70S6K↓, HK2↓, survivin↓, BioAv↝, Half-Life↝, ROS↑,
8527- Matr,    Matrine Promotes Human Myeloid Leukemia Cells Apoptosis Through Warburg Effect Mediated by Hexokinase 2
- in-vitro, AML, K562
TumCP↓, Apoptosis↑, Warburg↓, HK2↓, Synergy↑, Glycolysis↓,
8560- Matr,    Matrine: A Promising Natural Product With Various Pharmacological Activities
- Review, AD, NA - Review, Stroke, NA - Review, Var, NA
*antiAll↑, *Stroke↓, *AntiArt↑, TumCCA↑, VEGF↓, Apoptosis↑, P53↑, P21↑, PCNA↓, EIF4E↓, TumCP↓, TumCMig↓, IAP1↓, ROS↑, EMT↓, PAX2↓, ER Stress↑, HK2↓, Apoptosis↑, STAT3↓, mtDam↑, HMGB1↓, ChemoSen↑, p‑GSK‐3β↓, P-gp/ABCB1↓, MRP1/ABCC1↓, Vim↓, cycD1/CCND1↓, CDK4↓, GSH↓, SOD↓, mt-Cyt‑c↓, BAX↑, MMP9↓, MMP2↓, E-cadherin↓, N-cadherin↓, FOXO1↓, FOXO3↓, FOXO4↓, PI3K↓, ATF4↑, CHOP/DDIT3↑, *Aβ↓, *RAGE↓, *memory↑, *Learn↑, *cognitive↑, *MDA↓, *SOD↑, *GPx↑, *Catalase↑, *antiAll↑, *AHR↓, *SOCS-3↓, *ICAM-1↓, *ROS↓, cachexia↓, *BACE/β-secretase↓, *NF-kB↓, *TNF-α↓, *IL1β↓,
2450- Matr,    The Promoting Role of HK II in Tumor Development and the Research Progress of Its Inhibitors
- Review, Var, NA
HK2↓, eff↓,
8714- MeJa,    Methyl jasmonate binds to and detaches mitochondria-bound hexokinase
- in-vitro, Colon, CT26
HK2↓, eff↝, mtDam↑, ATP↓, other↝,

Showing Research Papers: 51 to 100 of 172
Prev Page 2 of 4 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 172

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 2,   GPx↓, 2,   GPx↑, 1,   GPx4↓, 2,   GSH↓, 13,   GSTs↑, 1,   H2O2↑, 5,   HO-1↓, 1,   HO-1↑, 4,   Iron↑, 2,   lipid-P↓, 1,   lipid-P↑, 4,   MDA↑, 4,   NADH↓, 1,   NADPH/NADP+↓, 1,   NQO1↑, 1,   NRF2↓, 4,   NRF2↑, 7,   p‑NRF2↓, 1,   Prx4↑, 1,   ox-PrxI↑, 1,   RNS↑, 1,   ROS↓, 4,   ROS↑, 66,   ROS⇅, 1,   ROS↝, 1,   i-ROS↑, 1,   mt-ROS↑, 3,   SOD↓, 1,   SOD↑, 1,   SOD1↑, 1,   SOD2↑, 1,   TKT↝, 1,   Trx1↓, 1,   TrxR↓, 4,   TrxR1↓, 1,   xCT/SLC7A11↓, 3,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 1,   NCOA4↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   CDC2↓, 1,   CDC25↓, 1,   compI↓, 1,   ETC↓, 2,   mitResp↓, 4,   mtDam↑, 13,   OCR↓, 4,   OCR↑, 2,   OXPHOS↓, 7,   OXPHOS↑, 2,   mt-OXPHOS↓, 3,   PDH↓, 8,   PDH↑, 1,   SDH↓, 1,   SDH↑, 1,   SIRT3↑, 1,   VDAC1↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACC↓, 2,   ACC-α↓, 1,   ACC1↓, 3,   ACLY↓, 2,   ACSL1↓, 1,   ALAT↓, 2,   ALDOA↓, 1,   ALDOB↑, 1,   AminoA↓, 1,   AMPK↑, 15,   p‑AMPK↑, 2,   ATP↓, 42,   ATP↝, 1,   ATP:AMP↓, 1,   CAIX/CA9↓, 1,   citrate↓, 1,   CPT1A↓, 3,   ECAR↓, 9,   ENO1↓, 3,   ENO3↑, 1,   FAO↓, 1,   FAO↑, 1,   FASN↓, 9,   FASN↑, 1,   FBP1↑, 1,   FBPase↑, 1,   G6PD↓, 6,   GAPDH↓, 4,   GLO-I↓, 1,   GLS↓, 3,   glucoNG↓, 1,   glucoNG↑, 1,   glucose↓, 1,   GlucoseCon↓, 46,   GlucoseCon↑, 3,   glut↓, 1,   GlutaM↓, 2,   Glycolysis↓, 105,   Glycolysis↑, 2,   GPI↓, 1,   GSK‐3β↓, 2,   GSK‐3β↑, 1,   GSK‐3β↝, 1,   p‑GSK‐3β↓, 2,   HAGH/GLO2↓, 1,   HK1↓, 4,   HK2?, 1,   HK2↓, 152,   HK2↑, 2,   HK2∅, 1,   HK3↑, 1,   lactateProd↓, 47,   lactateProd↑, 3,   LDHA↓, 44,   LDHA↑, 1,   LDHA∅, 1,   LDL↓, 1,   MCT4↓, 1,   NAD↓, 1,   NADPH↓, 5,   PCK1↑, 1,   PDK1 / PDPK1↓, 14,   PDK3↓, 1,   PDKs↓, 1,   PFK↓, 13,   PFK1↓, 11,   PFK1↑, 1,   PFK2?, 1,   PFK2↓, 2,   PFKFB3↓, 1,   PFKP?, 1,   PFKP↓, 3,   PGK1↓, 1,   PGK2↑, 1,   PGM1↑, 1,   PGM3↑, 1,   PKLR↑, 1,   PKM2↓, 51,   PKM2↑, 1,   p‑PKM2↓, 1,   PKM2:PKM1↓, 1,   PPP↓, 4,   Pyruv↓, 4,   R5P↝, 1,   SCD1↓, 1,   SIRT1↓, 1,   SIRT1↑, 1,   SIRT2↓, 1,   SREBP1/SREBF1?, 1,   SREBP1/SREBF1↓, 1,   SREBP2↓, 1,   TCA↓, 4,   TPI↓, 1,   Warburg↓, 18,   Warburg↑, 1,   β-oxidation↓, 3,  

Cell Death(tgid=5) ⓘ

AIF↓, 1,   AIF↑, 3,   APAF1↑, 1,   Apoptosis?, 2,   Apoptosis↑, 53,   mt-Apoptosis↑, 1,   ASK1↑, 1,   BAD↑, 2,   BAX↓, 2,   BAX↑, 14,   Bax:Bcl2↑, 4,   Bcl-2↓, 14,   Bcl-xL↓, 4,   BIM↑, 1,   BNIP3↓, 1,   BNIP3↝, 1,   Casp↑, 6,   Casp∅, 1,   Casp12↑, 1,   Casp2↑, 1,   Casp3↓, 2,   Casp3↑, 24,   cl‑Casp3↓, 1,   cl‑Casp3↑, 3,   proCasp3↓, 2,   Casp7↑, 3,   Casp8↑, 4,   cl‑Casp8↑, 2,   Casp9↑, 10,   cFLIP↓, 1,   Cyt‑c↓, 1,   Cyt‑c↑, 17,   mt-Cyt‑c↓, 1,   DR5↑, 1,   Endon↑, 1,   Fas↑, 1,   FasL↑, 1,   Ferroptosis↓, 1,   Ferroptosis↑, 3,   GSDME↑, 1,   GSDME-N↑, 1,   IAP1↓, 2,   iNOS↓, 1,   iNOS↑, 1,   Mcl-1↓, 5,   MDM2↓, 2,   MEG3↑, 1,   Necroptosis↑, 1,   necrosis↑, 1,   p38↑, 1,   PUMA↑, 1,   Pyro↑, 2,   RIP3↑, 1,   survivin↓, 7,   TRAIL↑, 2,   TumCD↑, 5,   XIAP↓, 3,   YAP/TEAD↓, 1,   YAP/TEAD↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 37,   Akt↑, 1,   p‑Akt↓, 6,   p‑Akt↑, 2,   AKT1↓, 4,   AMPKα↑, 1,   CaMKII ↓, 1,   cMET↓, 1,   p‑cMET↑, 1,   EGFR↓, 12,   ERK↓, 10,   ERK↑, 1,   p‑ERK↓, 1,   HER2/EBBR2↓, 4,   p‑HER2/EBBR2↓, 1,   IGF-1R↓, 1,   IKKα↓, 1,   IKKα↑, 1,   JAK1↓, 1,   JAK2↓, 2,   JNK↓, 2,   JNK↑, 2,   p‑JNK↓, 1,   MAP2K1/MEK1↓, 1,   MAPK↓, 3,   MAPK↑, 1,   mTOR↓, 19,   p‑mTOR↓, 3,   P70S6K↓, 4,   PFKFB2↓, 1,   PHKG1↑, 1,   PI3K↓, 19,   PI3K↑, 1,   PI3K/Akt↓, 1,   PKA↓, 5,   PKCδ↓, 2,   PP2A↑, 1,   PRAS40↑, 1,   PTEN↑, 11,   Raf↓, 1,   RAS↓, 2,   RIP1↓, 1,   RIP1↑, 1,   SHP1↑, 1,   Sp1/3/4↓, 6,   p‑Src↓, 1,   STAT3↓, 12,   p‑STAT3↓, 5,   p‑STAT3↑, 1,   p‑STAT5↓, 1,   STAT6↓, 1,   THEM4/CTMP↑, 1,   TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↑, 5,   ATF4↝, 1,   cMyc↓, 21,   DNMT1↓, 1,   DNMTs↓, 1,   FOXO1↓, 1,   FOXO3↓, 2,   FOXO3↑, 1,   p‑FOXO3↓, 1,   FOXO4↓, 1,   H3↓, 1,   H3K9↓, 1,   HATs↓, 1,   HDAC↓, 6,   HDAC3↓, 1,   HDAC4↓, 1,   HDAC8↓, 2,   HMTs↓, 1,   miR-122-5p↑, 1,   miR-126↑, 1,   miR-140↑, 1,   miR-145↑, 1,   miR-195↑, 1,   miR-199↑, 1,   miR-200c↑, 1,   miR-206↑, 1,   miR-21↓, 1,   miR-21↑, 1,   miR-221↑, 1,   miR-222↑, 1,   miR-29b↓, 1,   miR-326-5p↑, 1,   miR-34b-5p↑, 1,   Myc↓, 1,   OCT4↓, 4,   other↑, 1,   other↝, 3,   PAX2↓, 1,   SOX2↓, 3,   SOX4↑, 1,   TET3↑, 1,   tumCV↓, 7,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↑, 7,   eIF2α↓, 1,   eIF2α↑, 4,   p‑eIF2α↑, 2,   ER Stress↑, 13,   GRP78/BiP↑, 4,   GRP78/BiP↝, 1,   p‑Hsc70↑, 1,   HSP90↓, 2,   PERK↑, 5,   UPR↑, 6,   XBP-1↓, 1,   XBP-1↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↑, 1,   ATG5↑, 1,   ATG5↝, 1,   ATG7↑, 1,   Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 1,   Beclin-1/ATG6↝, 1,   p‑Beclin-1/ATG6↑, 1,   LAMP2↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 3,   LC3B↑, 1,   LC3B-II↑, 1,   LC3II↑, 2,   p62↓, 3,   p62↑, 1,   RUBCN↓, 1,   TumAuto↑, 16,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 2,   p‑ATM↑, 1,   DNAdam↓, 1,   DNAdam↑, 7,   DNAdam⇅, 1,   DNArepair↓, 1,   hTERT/TERT↓, 6,   NKX3.1↓, 1,   P53↑, 15,   PARP↓, 1,   PARP↑, 1,   cl‑PARP↑, 10,   proPARP↓, 2,   PCNA↓, 4,   SIRT6↑, 1,   TOP1↓, 1,   TOP2↓, 3,   TP53↓, 1,   TP53↑, 1,   γH2AX↑, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 3,   p‑CDK1↓, 1,   CDK2↓, 3,   CDK4↓, 4,   CDK6↓, 2,   CDKN1C/p57↑, 1,   cycA1/CCNA1↓, 2,   CycB/CCNB1↓, 5,   cycD1/CCND1↓, 14,   cycD1/CCND1↑, 1,   Ki-67↓, 7,   mitA↑, 1,   P21↓, 2,   P21↑, 11,   p27/CDKN1B↑, 4,   p‑pRB↓, 1,   RB1↓, 1,   p‑RB1↓, 1,   TumCCA↓, 1,   TumCCA↑, 28,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   p‑4E-BP1↓, 1,   ALDH↓, 2,   ALDH1A1↓, 1,   BMI1↓, 1,   CD24↓, 1,   cFos↓, 1,   CSCs↓, 4,   EIF4E↓, 1,   Gli1↓, 2,   HH↓, 1,   IGF-1↓, 1,   Ki-67↓, 7,   Let-7↑, 2,   mTORC1↓, 3,   Nanog↓, 4,   Nestin↓, 1,   NOTCH↓, 2,   NOTCH1↑, 2,   Shh↓, 3,   Smo↓, 2,   STAT1↓, 1,   TumCG↓, 25,   TumCG↑, 2,   TumCP↓, 41,   TumCP↑, 1,   Wnt↓, 6,  

Migration(tgid=13) ⓘ

AP-1↓, 2,   Ca+2↓, 2,   Ca+2↑, 8,   i-Ca+2↑, 1,   E-cadherin↓, 1,   E-cadherin↑, 11,   EMT↓, 12,   FAK↓, 1,   p‑FAK↓, 1,   Fibronectin↓, 1,   MALAT1↓, 1,   MET↓, 1,   MMP-10↓, 2,   MMP2↓, 9,   MMP3↓, 1,   MMP7↓, 2,   MMP9↓, 12,   MMPs↓, 4,   MUC4↓, 2,   N-cadherin↓, 7,   Slug↓, 5,   Snail↓, 5,   talin↓, 1,   TET1↑, 3,   TGF-β↓, 1,   TIMP1↓, 2,   TIMP1↑, 1,   TIMP2↓, 1,   TIMP2↑, 1,   TSC1↑, 1,   TumCA↓, 1,   TumCA↑, 1,   TumCI↓, 20,   TumCMig↓, 16,   TumMeta↓, 14,   Twist↓, 7,   TXNIP↓, 1,   uPA↓, 1,   Vim↓, 9,   Zeb1↓, 1,   α-SMA↓, 2,   α-SMA↑, 1,   α-tubulin↓, 1,   β-catenin/ZEB1↓, 9,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 12,   CD31/PECAM-1↓, 1,   eNOS↑, 1,   HIF-1↓, 1,   Hif1a↓, 35,   Hif1a↑, 2,   Hypoxia↑, 1,   LOX1↓, 1,   NO↓, 2,   NO↑, 4,   VEGF↓, 12,   VEGFR2/KDR/Flk1↓, 1,  

Barriers & Transport(tgid=15) ⓘ

CLDN1↓, 2,   CLDN2↓, 1,   GLUT1↓, 40,   GLUT1↑, 2,   GLUT2↓, 4,   GLUT3↓, 5,   GLUT4↓, 7,   MMP↓, 28,   MMP↑, 2,   MPT↑, 1,   ZO-1↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD25+↑, 1,   CD4+↑, 2,   CD44↓, 3,   CD8+↑, 1,   COX2/PTGS2↓, 8,   COX2/PTGS2↑, 2,   CXCR4↓, 2,   FOXP3↑, 1,   HCAR1↓, 1,   HMGB1↓, 1,   ICAM-1↓, 1,   Igs↑, 1,   IL10↓, 3,   IL17↓, 1,   IL1β↓, 4,   IL1β↑, 1,   IL4↓, 1,   IL6↓, 9,   IL8↓, 1,   Imm↑, 2,   Imm↝, 1,   Inflam↓, 5,   IRAK4↓, 1,   MCT1↓, 2,   NF-kB↓, 23,   p‑NF-kB↓, 1,   NK cell↑, 5,   NLRP3↓, 3,   p65↓, 1,   PD-L1↓, 3,   PGE2↓, 1,   PSA↓, 3,   RAGE↑, 1,   T-Cell↑, 1,   T-Cell↝, 1,   TCF↓, 1,   TLR4↓, 5,   TNF-α↓, 4,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,  

Cellular Microenvironment(tgid=17) ⓘ

pH↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↑, 1,   APP↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 3,   ER(estro)↓, 2,   PPARα↓, 1,   PPARγ↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 2,   BioAv↓, 7,   BioAv↑, 8,   BioAv↝, 3,   BioEnh?, 1,   BioEnh↑, 2,   ChemoSen↓, 2,   ChemoSen↑, 33,   ChemoSen⇅, 1,   Dose?, 1,   Dose↓, 1,   Dose↝, 12,   Dose∅, 3,   eff↓, 19,   eff↑, 23,   eff↝, 2,   Half-Life↓, 1,   Half-Life↝, 2,   MDR1↓, 2,   MRP1/ABCC1↓, 2,   P-gp/ABCB1↓, 3,   P-gp/ABCB1∅, 1,   P450↓, 1,   RadioS↑, 10,   RadioS↝, 1,   selectivity↑, 16,   Synergy↑, 28,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 2,   ALP↓, 1,   AR↓, 3,   AST↓, 1,   BG↓, 1,   EGFR↓, 12,   HER2/EBBR2↓, 4,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 6,   IL6↓, 9,   LDH↓, 13,   LDH↑, 2,   Myc↓, 1,   PD-L1↓, 3,   PSA↓, 3,   RAGE↑, 1,   TP53↓, 1,   TP53↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan?, 1,   AntiCan↑, 4,   AntiTum↑, 3,   cachexia↓, 2,   cardioP↑, 3,   chemoP↓, 1,   chemoPv↑, 2,   hepatoP↑, 1,   memory↑, 1,   neuroP↑, 3,   OS↑, 4,   radioP↑, 1,   RenoP↑, 1,   Strength↑, 1,   toxicity↓, 5,   toxicity↑, 3,   toxicity↝, 2,   TumVol↓, 7,   TumW↓, 5,   Weight∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   Bacteria↓, 2,   GutMicro↑, 2,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 2,  
Total Targets: 594

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 1,   antiOx↑, 8,   ARE↑, 1,   Catalase↑, 6,   GPx↑, 4,   GPx1↑, 2,   GPx4↑, 2,   GSH↑, 6,   GSR↑, 2,   GSTs↑, 3,   HDL↑, 2,   HO-1↑, 2,   lipid-P↓, 4,   lipidDe↓, 1,   MDA↓, 3,   NQO1↑, 2,   NRF2↑, 5,   Prx↑, 1,   ROS↓, 15,   ROS↑, 1,   mt-ROS↓, 1,   SOD↑, 7,   SOD1↑, 1,   TAC↑, 1,   Trx↓, 1,   Trx↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

Insulin↓, 1,   mitResp↓, 1,   OCR↓, 1,   OXPHOS↓, 2,   OXPHOS↑, 1,   PGC-1α↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

ACC↓, 1,   p‑ACC↑, 1,   ALAT↓, 1,   ALDOA↑, 1,   p‑AMPK↑, 1,   ATP↑, 3,   ECAR↓, 1,   ECAR↑, 1,   FAO↑, 1,   G6PD↑, 1,   glucose↓, 1,   glucose↝, 1,   GlucoseCon↓, 4,   GlucoseCon↑, 1,   Glycolysis↓, 4,   Glycolysis↑, 5,   Glycolysis↝, 2,   GPI↑, 1,   H2S↑, 1,   HK2↓, 8,   HK2↑, 8,   IDH1↑, 1,   lactateProd↓, 4,   LDHA↓, 2,   LDHA↑, 3,   LDL↓, 1,   lipidLev↓, 1,   NADPH↓, 2,   NADPH↑, 1,   PDKs↓, 1,   PFK↓, 2,   PFK↑, 1,   PFK1↓, 1,   PFK2↓, 1,   PFKL↑, 3,   PFKM↑, 2,   PFKP↓, 1,   PFKP↑, 1,   PKM1↑, 1,   PKM2↓, 4,   PKM2↑, 5,   PPP↓, 1,   SIRT1↑, 1,   SIRT2↑, 1,   SREBP1/SREBF1↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↓, 3,   Casp3↓, 1,   Casp9↓, 1,   iNOS↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   IGFR↓, 1,   MAPK↓, 1,   mTOR↓, 1,   PFKFB2↓, 1,   PI3K↓, 1,   PTEN↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF4↑, 1,   other↝, 2,   tumCV↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

IGF-1↓, 2,  

Migration(tgid=13) ⓘ

AntiAg↑, 1,   TumCMig↑, 1,   TXNIP↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↑, 2,   E-sel↓, 1,   Hif1a↓, 2,   Hif1a↑, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

GLUT1↑, 2,   GLUT4↑, 3,   MMP↑, 1,   MMP↝, 1,   MUC5AC↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CCL11↓, 1,   COX2/PTGS2↓, 3,   CXCL1↓, 1,   ICAM-1↓, 1,   IL10↓, 1,   IL17↓, 1,   IL1β↓, 2,   IL2↓, 1,   IL6↓, 1,   IL8↓, 1,   Inflam↓, 12,   NF-kB↓, 5,   RAGE↓, 1,   SOCS-3↓, 1,   TNF-α↓, 4,  

Cellular Microenvironment(tgid=17) ⓘ

pH↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↑, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 2,   BACE/β-secretase↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AHR↓, 1,   FGF21↑, 1,   PPARα↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 6,   BioAv↑, 2,   BioAv↝, 1,   BioEnh↑, 1,   Dose?, 1,   Dose↝, 3,   P450↓, 1,   selectivity↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 1,   AST↓, 2,   IL6↓, 1,   RAGE↓, 1,   TC↓, 1,   TG/TAG↓, 1,   VLDL↓, 1,  

Functional Outcomes(tgid=23) ⓘ

antiAll↑, 4,   AntiArt↑, 2,   AntiDiabetic↑, 1,   cardioP↑, 4,   chemoP↑, 1,   cognitive↑, 3,   hepatoP↑, 7,   Learn↑, 1,   memory↑, 2,   neuroP↓, 1,   neuroP↑, 7,   OS↑, 1,   RenoP↑, 2,   Stroke↓, 1,   toxicity↓, 5,   toxicity↝, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 1,   AntiP↑, 1,   AntiViral↑, 1,   Bacteria↓, 1,   GutMicro↑, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 1,  
Total Targets: 164

Scientific Paper Hit Count for: HK2, Hexokinase 2
14 3-bromopyruvate
9 Sulforaphane (mainly Broccoli)
8 Quercetin
8 Propolis -bee glue
7 2-DeoxyGlucose
7 Baicalein
7 EGCG (Epigallocatechin Gallate)
7 Resveratrol
6 Metformin
6 Chrysin
5 Shikonin
4 Curcumin
4 Graviola
4 Methyl Jasmonate
3 Berberine
3 Capsaicin
3 Citric Acid
3 Fenbendazole
3 Matrine
3 Ursolic acid
2 Apigenin (mainly Parsley)
2 Baicalin
2 Cinnamon
2 Chemotherapy
2 Emodin
2 Kaempferol
2 Licochalcone A
2 Licorice
2 Magnetic Fields
2 Pachymic acid
2 Piperlongumine
2 Silymarin (Milk Thistle) silibinin
2 Vitamin C (Ascorbic Acid)
2 Vitamin D3
1 Sorafenib (brand name Nexavar)
1 Radiotherapy/Radiation
1 cetuximab
1 Alpha-Lipoic-Acid
1 doxorubicin
1 Artemisinin
1 Ashwagandha(Withaferin A)
1 5-fluorouracil
1 Betulinic acid
1 Benzyl isothiocyanate
1 Caffeic acid
1 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
1 Chlorogenic acid
1 chaetocin
1 Deguelin
1 Diclofenac
1 diet FMD Fasting Mimicking Diet
1 diet Methionine-Restricted Diet
1 Taurine
1 Piperine
1 flavonoids
1 Ginkgolide B
1 Hydrogen Gas
1 Honokiol
1 Isorhamnetin
1 Isothiocyanates
1 Ivermectin
1 Laetrile B17 Amygdalin
1 lambertianic acid
1 Luteolin
1 Magnolol
1 Methylglyoxal
1 Melatonin
1 Moringa oleifera
1 Oroxylin-A
1 Proanthocyanidins
1 Phenylbutyrate
1 Rosmarinic acid
1 Terpenoids
1 Thymoquinone
1 triptolide
1 Vitamin K2
1 Wogonin
1 Worenine
1 γ-Tocotrienol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:773  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page